Valeur202020212022202320242025Total du passif73.18 M78.99 M83.99 M88.86 M81.96 M57.88 MTotal des capitaux propres18.54 M184.38 M96.37 M266.32 M336.5 M306.11 MTotal du passif et des capitaux propres91.72 M263.37 M180.36 M355.18 M418.46 M364 MDette totale37.98 M36.56 M29.31 M29.31 M——Dette nette37.98 M-175.04 M-115.29 M-301.69 M——
EyePoint, Inc. - Common Stock
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner.
In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc.